UNSPSC 51453006: Piperazine citrate anhydrous

This classification denotes an antihelminthic agent with the molecular formula 2C6H8O7.3C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RI85381D5G, chemically known as piperazine, 2-hydroxy-1,2,3-propanetricarboxylate (3:2), but more generally known as piperazine citrate anhydrous, which bears US NIH Compound Identifier 114763. European Medicines Agency schedules piperazine citrate anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03841MIG.

Most nations, for tariff purposes, schedule piperazine citrate anhydrous under HS 29335990. SMILES: C1CNCCN1.C1CNCCN1.C1CNCCN1.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

UNSPSC 51453006 Piperazine citrate anhydrous is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement. The recent opportunities tagged to this code show little connection to piperazine citrate anhydrous, a pharmaceutical intermediate or active pharmaceutical ingredient. Instead, the tagged solicitations span naloxone procurement, direct-to-manufacturer prescription programs, medical and first aid supplies for fire departments, and generic multi-source pharmaceuticals and OTC products. The mismatch suggests either a cataloging error in the source data or that the code is being applied to a broader pharmaceutical and medical-supply family than its nominal scope indicates.

The geographic spread of recent opportunities includes Florida (Seminole County), Texas (HHS Commission), Florida (City of Tampa), and Minnesota (MMCAP cooperative), with issuing bodies ranging from county health departments and state health agencies to municipal fire departments and cooperative purchasing alliances serving multi-state memberships. The most recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023, though the posting date of June 30, 2026 appears inconsistent with the due date), the City of Tampa's ITB for medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a designated small local business enterprise set-aside (due March 13, 2026), Minnesota MMCAP's RFP for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers (due March 26, 2026), and the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026). Given the disconnect between the code's nominal definition and the actual scope of tagged opportunities, use of this code for business development filtering is not recommended without clarification from the source procurement office.